- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 608
TScan eases to $35m series B close
Subsidiaries of Astellas and Novartis co-led a round featuring GV and 6 Dimensions Capital that took the cancer drug developer's overall funding to $60m.
Jan 14, 2020BoCloud beckons Nio for series C round
Nio Capital has led a $14.5m series C round for BoCloud that also attracted existing backer JD Cloud, a contributor to its last round.
Jan 14, 2020BioSkryb bids hello to seed funding
Wilson Sonsini Goodrich & Rosati has invested in genomic sequencing amplification startup BioSkryb as part of an $11.5m round.
Jan 13, 2020Practifi pockets series B funding
Salesforce Ventures-backed financial customer communication platform Practifi has raised $16.3m for recruitment and product development.
Jan 13, 2020Weld North takes LearnZillion under its wing
Weld North Education has purchased OATV-backed digital education product supplier LearnZillion, which had raised more than $22.4m in funding.
Jan 13, 2020Lightnet speeds to series A round
The remittance services startup raised $31.2m from backers including HashKey, UOB, Seven Bank, Uni-President Enterprises and Hanwha.
Jan 13, 2020Alitheon aligns with BMW for funding
BMW iVentures has invested in Alitheon as part of a $14.9m round that will enable it to expand its supply chain-analysis software into new industries.
Jan 13, 2020Daily deal net: January 13, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Jan 13, 2020Jasper grasps $50m
Jasper Therapeutics, based in part on Stanford research, has raised a $15m series A extension on the back of early clinical results from its blood transplant conditioning program.
Jan 13, 2020Novome navigates $33m series A round
Mayo Clinic has bet on chronic disease drug developer Novome Biotechnologies, which is initially targeting a disorder known as hyperoxaluria.
Jan 13, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


